Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin | 22 | 2024 | 2977 | 1.600 |
Why?
|
Receptors, Androgen | 16 | 2024 | 1089 | 1.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 31 | 2024 | 8621 | 0.990 |
Why?
|
Central Serous Chorioretinopathy | 2 | 2022 | 32 | 0.960 |
Why?
|
Paraffin Embedding | 3 | 2020 | 303 | 0.930 |
Why?
|
Tissue Fixation | 3 | 2020 | 245 | 0.920 |
Why?
|
Transcription Factors | 20 | 2024 | 12150 | 0.910 |
Why?
|
Enhancer Elements, Genetic | 8 | 2021 | 1363 | 0.790 |
Why?
|
Epigenesis, Genetic | 16 | 2024 | 3824 | 0.690 |
Why?
|
Prostatic Neoplasms | 16 | 2024 | 11094 | 0.690 |
Why?
|
Histones | 12 | 2024 | 2593 | 0.680 |
Why?
|
Lysine | 4 | 2020 | 997 | 0.590 |
Why?
|
Cell Line, Tumor | 43 | 2024 | 17088 | 0.580 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 343 | 0.570 |
Why?
|
Workflow | 2 | 2021 | 859 | 0.550 |
Why?
|
Sequence Analysis, RNA | 6 | 2023 | 2039 | 0.520 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2023 | 3666 | 0.520 |
Why?
|
Drug Resistance, Neoplasm | 11 | 2024 | 5329 | 0.500 |
Why?
|
Histone Code | 1 | 2016 | 160 | 0.490 |
Why?
|
Breast Neoplasms | 17 | 2024 | 21162 | 0.440 |
Why?
|
Gene Expression Profiling | 11 | 2023 | 9525 | 0.420 |
Why?
|
Computational Biology | 4 | 2023 | 3564 | 0.420 |
Why?
|
Sequence Analysis, DNA | 7 | 2023 | 4780 | 0.390 |
Why?
|
Chromatin Immunoprecipitation | 6 | 2017 | 856 | 0.380 |
Why?
|
Software | 6 | 2023 | 4466 | 0.380 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 6 | 2022 | 166 | 0.360 |
Why?
|
Neoplasms | 10 | 2023 | 22350 | 0.360 |
Why?
|
Cell Proliferation | 17 | 2024 | 10445 | 0.350 |
Why?
|
Small Cell Lung Carcinoma | 3 | 2024 | 454 | 0.350 |
Why?
|
Signal Transduction | 16 | 2024 | 23619 | 0.330 |
Why?
|
Acetylation | 7 | 2020 | 1054 | 0.320 |
Why?
|
Formaldehyde | 3 | 2023 | 360 | 0.320 |
Why?
|
Up-Regulation | 4 | 2024 | 4142 | 0.310 |
Why?
|
SOX9 Transcription Factor | 2 | 2021 | 145 | 0.310 |
Why?
|
Phenylthiohydantoin | 4 | 2024 | 206 | 0.310 |
Why?
|
Leukemia | 3 | 2024 | 1521 | 0.310 |
Why?
|
Epigenomics | 6 | 2024 | 959 | 0.310 |
Why?
|
Chromosomal Proteins, Non-Histone | 4 | 2024 | 723 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 10 | 2024 | 3607 | 0.290 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 1144 | 0.290 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2022 | 2184 | 0.290 |
Why?
|
Mice | 36 | 2024 | 81889 | 0.270 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2024 | 2839 | 0.270 |
Why?
|
Transcription, Genetic | 9 | 2020 | 7609 | 0.250 |
Why?
|
Cyclin-Dependent Kinase 4 | 4 | 2022 | 562 | 0.250 |
Why?
|
Animals | 45 | 2024 | 168930 | 0.240 |
Why?
|
NFI Transcription Factors | 1 | 2024 | 49 | 0.240 |
Why?
|
RNA, Messenger | 2 | 2018 | 12791 | 0.230 |
Why?
|
Alternative Splicing | 3 | 2024 | 1103 | 0.230 |
Why?
|
DNA-Binding Proteins | 7 | 2024 | 9611 | 0.230 |
Why?
|
Histone Demethylases | 2 | 2024 | 328 | 0.230 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2024 | 42 | 0.220 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2024 | 139 | 0.220 |
Why?
|
Nuclear Proteins | 6 | 2023 | 5795 | 0.220 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1097 | 0.220 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2022 | 792 | 0.220 |
Why?
|
Transcriptional Activation | 4 | 2022 | 1749 | 0.220 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13485 | 0.220 |
Why?
|
p21-Activated Kinases | 1 | 2024 | 127 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 79 | 0.210 |
Why?
|
Glycocalyx | 1 | 2024 | 99 | 0.210 |
Why?
|
Cell Differentiation | 7 | 2024 | 11651 | 0.210 |
Why?
|
Humans | 91 | 2024 | 766766 | 0.210 |
Why?
|
Prostate | 6 | 2023 | 1757 | 0.210 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 1884 | 0.200 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2022 | 790 | 0.200 |
Why?
|
HMGN1 Protein | 2 | 2020 | 27 | 0.200 |
Why?
|
Receptors, Estrogen | 3 | 2022 | 2251 | 0.200 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1802 | 0.190 |
Why?
|
SOXB1 Transcription Factors | 2 | 2021 | 283 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2021 | 2948 | 0.190 |
Why?
|
Brain Neoplasms | 4 | 2024 | 9101 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2021 | 352 | 0.190 |
Why?
|
Cell Lineage | 6 | 2024 | 2572 | 0.180 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 193 | 0.180 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2020 | 30 | 0.180 |
Why?
|
Lasers | 2 | 2022 | 951 | 0.180 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2020 | 39 | 0.180 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2023 | 150 | 0.180 |
Why?
|
Fixatives | 1 | 2020 | 90 | 0.180 |
Why?
|
Esophageal Neoplasms | 2 | 2021 | 1660 | 0.180 |
Why?
|
Azepines | 3 | 2020 | 329 | 0.180 |
Why?
|
Protein Binding | 8 | 2021 | 9320 | 0.180 |
Why?
|
Mutation | 10 | 2024 | 30213 | 0.180 |
Why?
|
Androgen Antagonists | 3 | 2022 | 1411 | 0.180 |
Why?
|
Pyelonephritis | 1 | 2020 | 77 | 0.180 |
Why?
|
Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.170 |
Why?
|
Oncogene Proteins | 2 | 2020 | 715 | 0.170 |
Why?
|
Fluorescein Angiography | 2 | 2022 | 1086 | 0.160 |
Why?
|
Ribonucleoside Diphosphate Reductase | 1 | 2019 | 31 | 0.160 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 321 | 0.160 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4522 | 0.160 |
Why?
|
Angiomyolipoma | 1 | 2020 | 189 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 253 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2019 | 755 | 0.160 |
Why?
|
Androgen Receptor Antagonists | 1 | 2019 | 123 | 0.160 |
Why?
|
Receptor, erbB-2 | 3 | 2024 | 2597 | 0.160 |
Why?
|
Deoxyribonuclease I | 3 | 2014 | 228 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2018 | 361 | 0.150 |
Why?
|
Ureteral Obstruction | 1 | 2020 | 293 | 0.150 |
Why?
|
Quinolines | 1 | 2024 | 769 | 0.150 |
Why?
|
Stromal Cells | 1 | 2024 | 1334 | 0.150 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 257 | 0.150 |
Why?
|
NF-kappa B | 2 | 2024 | 2493 | 0.150 |
Why?
|
RNA | 3 | 2023 | 2715 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 533 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 480 | 0.150 |
Why?
|
Antineoplastic Agents | 8 | 2022 | 13643 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 53 | 0.150 |
Why?
|
Mediator Complex | 2 | 2020 | 106 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2016 | 1756 | 0.140 |
Why?
|
Trisomy | 1 | 2018 | 260 | 0.140 |
Why?
|
Triazoles | 3 | 2020 | 902 | 0.140 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2017 | 70 | 0.140 |
Why?
|
Androgens | 1 | 2024 | 1280 | 0.140 |
Why?
|
Neuroendocrine Tumors | 2 | 2021 | 659 | 0.140 |
Why?
|
Estrogen Receptor alpha | 2 | 2018 | 581 | 0.140 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 11920 | 0.130 |
Why?
|
Genome | 2 | 2022 | 1752 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 480 | 0.130 |
Why?
|
Astrocytoma | 1 | 2020 | 773 | 0.130 |
Why?
|
Cell Nucleus | 2 | 2022 | 2870 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 712 | 0.130 |
Why?
|
Photochemotherapy | 1 | 2022 | 828 | 0.130 |
Why?
|
Oncogenes | 2 | 2022 | 1231 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 308 | 0.120 |
Why?
|
E2F1 Transcription Factor | 1 | 2015 | 182 | 0.120 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 309 | 0.120 |
Why?
|
Deoxyribonucleases | 1 | 2016 | 209 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2060 | 0.120 |
Why?
|
Binding Sites | 3 | 2019 | 6012 | 0.120 |
Why?
|
Tissue Banks | 1 | 2016 | 183 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1627 | 0.120 |
Why?
|
Nitriles | 4 | 2024 | 981 | 0.120 |
Why?
|
Male | 36 | 2024 | 364142 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2024 | 2028 | 0.120 |
Why?
|
Hepatocytes | 1 | 2022 | 1246 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2021 | 4652 | 0.120 |
Why?
|
Benzamides | 4 | 2024 | 1375 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 802 | 0.120 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 557 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1352 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2704 | 0.110 |
Why?
|
Inheritance Patterns | 1 | 2016 | 345 | 0.110 |
Why?
|
Base Sequence | 3 | 2021 | 12415 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2022 | 705 | 0.110 |
Why?
|
Cluster Analysis | 2 | 2018 | 2717 | 0.110 |
Why?
|
Sequence Alignment | 1 | 2018 | 2177 | 0.110 |
Why?
|
Quality Control | 1 | 2016 | 834 | 0.110 |
Why?
|
Gene Regulatory Networks | 3 | 2024 | 1751 | 0.110 |
Why?
|
DNA Repair | 2 | 2022 | 2050 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1351 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2013 | 49 | 0.110 |
Why?
|
Immunotherapy | 4 | 2023 | 4747 | 0.110 |
Why?
|
Models, Genetic | 2 | 2020 | 3450 | 0.110 |
Why?
|
Disease Progression | 4 | 2024 | 13640 | 0.110 |
Why?
|
Cell Survival | 5 | 2022 | 5748 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2902 | 0.100 |
Why?
|
BRCA1 Protein | 1 | 2019 | 1155 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2045 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1390 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1899 | 0.100 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2937 | 0.100 |
Why?
|
DNA Damage | 1 | 2022 | 2467 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2019 | 1964 | 0.100 |
Why?
|
Knowledge Bases | 1 | 2012 | 96 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6359 | 0.090 |
Why?
|
Female | 32 | 2024 | 396520 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2022 | 3609 | 0.090 |
Why?
|
Cell Cycle Proteins | 5 | 2022 | 3439 | 0.090 |
Why?
|
Nucleosomes | 3 | 2023 | 492 | 0.090 |
Why?
|
Homeodomain Proteins | 4 | 2023 | 2430 | 0.090 |
Why?
|
Promoter Regions, Genetic | 5 | 2024 | 5789 | 0.090 |
Why?
|
Organoids | 3 | 2022 | 740 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2013 | 661 | 0.090 |
Why?
|
Down-Regulation | 1 | 2018 | 2931 | 0.090 |
Why?
|
Apoptosis | 3 | 2023 | 9513 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 916 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1838 | 0.080 |
Why?
|
RNA, Double-Stranded | 2 | 2021 | 292 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2012 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3043 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6962 | 0.080 |
Why?
|
Cell Line | 5 | 2024 | 15563 | 0.080 |
Why?
|
DNA | 1 | 2023 | 7208 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3757 | 0.080 |
Why?
|
RNA Polymerase II | 1 | 2013 | 549 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2534 | 0.080 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3944 | 0.080 |
Why?
|
Stents | 1 | 2020 | 3193 | 0.080 |
Why?
|
Gene Expression | 5 | 2022 | 7585 | 0.080 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 803 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5690 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2024 | 996 | 0.070 |
Why?
|
DNA Methylation | 4 | 2024 | 4427 | 0.070 |
Why?
|
Intestine, Small | 1 | 2014 | 1217 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3408 | 0.070 |
Why?
|
Information Storage and Retrieval | 1 | 2013 | 832 | 0.070 |
Why?
|
Interferons | 2 | 2021 | 714 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1900 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22352 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6895 | 0.070 |
Why?
|
HEK293 Cells | 3 | 2021 | 4276 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5783 | 0.070 |
Why?
|
Chromosome Mapping | 3 | 2023 | 4619 | 0.060 |
Why?
|
Peptides | 1 | 2018 | 4344 | 0.060 |
Why?
|
Paclitaxel | 2 | 2023 | 1727 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2426 | 0.060 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1434 | 0.060 |
Why?
|
Tamoxifen | 2 | 2022 | 967 | 0.060 |
Why?
|
Aging | 1 | 2024 | 8731 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4049 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6002 | 0.060 |
Why?
|
Methylnitrosourea | 1 | 2024 | 30 | 0.060 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2024 | 35 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2324 | 0.060 |
Why?
|
Liver | 1 | 2020 | 7571 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1362 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3636 | 0.060 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3609 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4282 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4904 | 0.050 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2024 | 220 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6104 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 16044 | 0.050 |
Why?
|
Mammary Glands, Animal | 1 | 2024 | 273 | 0.050 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2823 | 0.050 |
Why?
|
Cytarabine | 1 | 2024 | 696 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2021 | 6222 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 26 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2024 | 14471 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2024 | 502 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7475 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 496 | 0.050 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 309 | 0.050 |
Why?
|
Glucose Transporter Type 1 | 1 | 2022 | 186 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 313 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 187 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5444 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 81635 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 144 | 0.050 |
Why?
|
Deoxycytosine Nucleotides | 1 | 2020 | 13 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 391 | 0.050 |
Why?
|
Calmodulin | 1 | 2022 | 239 | 0.050 |
Why?
|
Prognosis | 4 | 2022 | 29948 | 0.040 |
Why?
|
Linkage Disequilibrium | 2 | 2016 | 1996 | 0.040 |
Why?
|
Genes, cdc | 1 | 2020 | 113 | 0.040 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 58 | 0.040 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2020 | 105 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2024 | 1337 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2020 | 190 | 0.040 |
Why?
|
Cyclin E | 1 | 2020 | 155 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 111 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2020 | 89 | 0.040 |
Why?
|
RNA Interference | 2 | 2021 | 2827 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2024 | 1716 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 698 | 0.040 |
Why?
|
Choroid | 1 | 2022 | 364 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 401 | 0.040 |
Why?
|
Phosphorylation | 2 | 2024 | 8307 | 0.040 |
Why?
|
Repressor Proteins | 2 | 2022 | 2978 | 0.040 |
Why?
|
Mucin-1 | 1 | 2024 | 536 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2024 | 960 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 176 | 0.040 |
Why?
|
Breast Neoplasms, Male | 1 | 2021 | 213 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1536 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
Gene Library | 1 | 2021 | 1065 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3601 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 872 | 0.040 |
Why?
|
Acrylamides | 1 | 2020 | 260 | 0.040 |
Why?
|
Chemotaxis | 1 | 2021 | 598 | 0.040 |
Why?
|
Introns | 1 | 2021 | 966 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 65273 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 505 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5861 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 330 | 0.040 |
Why?
|
Piperazines | 2 | 2021 | 2547 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1150 | 0.040 |
Why?
|
HMGB Proteins | 1 | 2018 | 45 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 116 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1250 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 375 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6512 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 980 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 857 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1750 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1756 | 0.040 |
Why?
|
Embryonic Development | 1 | 2022 | 722 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9547 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 545 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 18075 | 0.030 |
Why?
|
Aminopyridines | 1 | 2021 | 577 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 962 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2021 | 630 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1670 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2017 | 240 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1660 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4891 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 231 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2019 | 818 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2017 | 163 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 853 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1075 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16724 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 31 | 0.030 |
Why?
|
Stem Cells | 2 | 2023 | 3537 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1211 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 560 | 0.030 |
Why?
|
ROC Curve | 1 | 2024 | 3620 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 224 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 862 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1576 | 0.030 |
Why?
|
Genome, Human | 2 | 2021 | 4443 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12825 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 204 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1900 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 121 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1711 | 0.030 |
Why?
|
Mice, Nude | 1 | 2022 | 3616 | 0.030 |
Why?
|
Metabolism, Inborn Errors | 1 | 2017 | 291 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1110 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 776 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2470 | 0.030 |
Why?
|
Endonucleases | 1 | 2018 | 371 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 540 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 562 | 0.030 |
Why?
|
Cell Fusion | 1 | 2015 | 294 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 247 | 0.030 |
Why?
|
Antigens | 1 | 2020 | 1441 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1105 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5923 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 350 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1141 | 0.030 |
Why?
|
Ligands | 1 | 2021 | 3275 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1074 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 230 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3796 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 231 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2628 | 0.030 |
Why?
|
Cell Shape | 1 | 2015 | 372 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 711 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2023 | 2463 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2885 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1331 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9404 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 526 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2022 | 2448 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2413 | 0.030 |
Why?
|
Enterocytes | 1 | 2014 | 220 | 0.030 |
Why?
|
Estrogens | 1 | 2019 | 1528 | 0.020 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2413 | 0.020 |
Why?
|
Visual Acuity | 1 | 2022 | 2714 | 0.020 |
Why?
|
Gene Deletion | 1 | 2020 | 2669 | 0.020 |
Why?
|
K562 Cells | 1 | 2013 | 645 | 0.020 |
Why?
|
Genome-Wide Association Study | 3 | 2016 | 12806 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1609 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2017 | 1227 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2394 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2210 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2024 | 4400 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2495 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2013 | 928 | 0.020 |
Why?
|
Nucleotides | 1 | 2013 | 454 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1042 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1117 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3053 | 0.020 |
Why?
|
Mitochondria | 1 | 2024 | 3677 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2534 | 0.020 |
Why?
|
Middle Aged | 5 | 2024 | 223257 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2855 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18330 | 0.020 |
Why?
|
Estradiol | 1 | 2017 | 1947 | 0.020 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2013 | 661 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2212 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3425 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5503 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2018 | 3158 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2801 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2888 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2014 | 751 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1642 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3468 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23717 | 0.020 |
Why?
|
Breast | 1 | 2017 | 1971 | 0.020 |
Why?
|
Aged | 4 | 2024 | 171343 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2020 | 4924 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9357 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3691 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3073 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2015 | 2136 | 0.020 |
Why?
|
Adult | 4 | 2024 | 223307 | 0.020 |
Why?
|
Genetic Loci | 1 | 2016 | 2630 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6550 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2693 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5386 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1894 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11061 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13278 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11218 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4784 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7074 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74881 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3833 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9461 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3113 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7868 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18984 | 0.010 |
Why?
|
Child | 2 | 2022 | 80668 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10264 | 0.010 |
Why?
|
Cell Movement | 1 | 2015 | 5199 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22248 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3914 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 13036 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11872 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6207 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10384 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39309 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36461 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42577 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 41710 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59939 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88904 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36567 | 0.000 |
Why?
|